patient outcomes

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa

Kamban Hirasen, Rebecca Berhanu, Denise Evans, Sydney Rosen, Ian Sanne, Lawrence Long
Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43–48%, falling short of the World Health Organization’s target of ≥75%. We present rates and assess predictors of attrition by 12 months on treatment.
Include in home page features rotation
Subscribe to patient outcomes